MDxHealth annonce les résultats de son assemblée générale extraordinaire des actionnaires
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE 30 juin 2023, 2200 CEST MDxHealth annonce les résultats de son assemblée générale extraordinaire des actionnaires IRVINE, CA, et HERSTAL, BELGIQUE – le 30 juin 2023 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (“mdxhealth” ou la “Société“), une société de diagnostic de précision à un stade commercial, a […]
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director
NEWS RELEASE – REGULATED INFORMATION 25 May 2022, 4:00 p.m. EDT / 22:00 CET MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director IRVINE, CA, and HERSTAL, BELGIUM – 25 May 2022 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today […]
Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer
NEWS RELEASE – REGULATED INFORMATIONMay 19, 2022, 4:00PM EDT / 22:00 CET Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx® for Prostate Cancer IRVINE, CA, and HERSTAL, BELGIUM – May 19, 2022 – – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial stage precision diagnostics company, announces that Palmetto GBA, a Medicare Administrative […]
MDxHealth Reports Q1-2022 Results
NEWS RELEASE – REGULATED INFORMATION27 APRIL 2022, 4:00PM EDT / 22:00 CET MDxHealth Reports Q1-2022 Results IRVINE, CA, and HERSTAL, BELGIUM – April 27, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced its financial results for the first quarter ended March 31, 2022. Michael McGarrity, CEO of MDxHealth, […]
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 25 April 2022, 10:00 p.m. CET MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings IRVINE, CA, and HERSTAL, BELGIUM – 25 April 2022 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today invites the holders of securities issued by the […]
MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference
NEWS RELEASEMarch 30, 2022, 4:30 PM EST / 22:30 CET MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference IRVINE, CA, and HERSTAL, BELGIUM – March 30, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, CEO, will participate in the 14th Annual Kempen Life […]
MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022
NEWS RELEASE – REGULATED INFORMATION2 MARCH 2022, 4:00 PM EST / 22:00 CET MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022 Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 2, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage […]
MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd
NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd Company to Host Conference Call with Live Q&A, March 2, 2022 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 17, 2022 – MDxHealth […]
MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
NEWS RELEASE9 FEBRUARY 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference IRVINE, CA, and HERSTAL, BELGIUM – February 9, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced that the Company will present at the BTIG MedTech, […]
MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET MDxHealth Shareholder Transparency Declaration IRVINE, CA, and HERSTAL, BELGIUM – 10 December 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 […]
